Cleared Traditional

K143108 - HealthGuard-15

K143108 is the FDA 510(k) clearance for HealthGuard-15 by Futrex, Inc.. It is a Class 2 Cardiovascular device (product code DXN) cleared through the Traditional 510(k) pathway after a 149-day FDA review.

K143108 · Futrex, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2015
Decision
149d
Days
Class 2
Risk

K143108 is an FDA 510(k) clearance for the HealthGuard-15. Classified as System, Measurement, Blood-pressure, Non-invasive (product code DXN), Class II - Special Controls.

Submitted by Futrex, Inc. (Hagerstown, US). The FDA issued a Cleared decision on March 27, 2015 after a review of 149 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1130 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Futrex, Inc. devices

Submission Details

510(k) Number K143108 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 29, 2014
Decision Date March 27, 2015
Days to Decision 149 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
24d slower than avg
Panel avg: 125d · This submission: 149d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DXN System, Measurement, Blood-pressure, Non-invasive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1130
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXN System, Measurement, Blood-pressure, Non-invasive

All 439
Devices cleared under the same product code (DXN) and FDA review panel - the closest regulatory comparables to K143108.
Fully Automatic Electronic Blood Pressure Monitor
K151460 · Andon Health Co, Ltd. · Sep 2015
Full Automatic (NIBP)Blood Pressure Monitor
K150311 · Health & Life Co., Ltd. · Aug 2015
FULLY AUTOMATIC ELECTRONIC BLOOD PRESSURE MONITOR
K141984 · Andon Health Co, Ltd. · Apr 2015
Full Automatic (NIBP) Blood Pressure Monitor
K142968 · Health & Life Co., Ltd. · Dec 2014
BP652N (HEM-6300-Z)
K142917 · Omron Healthcare, Inc. · Dec 2014
FULLY AUTOMATIC ELECTRONIC BLOOD PRESSURE MONITOR
K140121 · Andon Health Co, Ltd. · Jul 2014